EP Patent

EP0997472A2 — Spirocyclic C-glycosides

Assigned to Eli Lilly and Co · Expires 2000-05-03 · 26y expired

What this patent protects

An improved and a new synthetic route for the preparation of spirocyclic C-glycoside compounds having the following general structure are described. Novel derivatives of spirocyclic C-glycoside compounds are also disclosed which may be used as intermediates in the synthesis and…

USPTO Abstract

An improved and a new synthetic route for the preparation of spirocyclic C-glycoside compounds having the following general structure are described. Novel derivatives of spirocyclic C-glycoside compounds are also disclosed which may be used as intermediates in the synthesis and evaluation of potential pharmaceutically active materials.

Drugs covered by this patent

Patent Metadata

Patent number
EP0997472A2
Jurisdiction
EP
Classification
—
Expires
2000-05-03
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.